Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioventus Inc Cl A (BVS)

Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 710,107
  • Shares Outstanding, K 82,763
  • Annual Sales, $ 573,280 K
  • Annual Income, $ -33,540 K
  • EBIT $ 85 M
  • EBITDA $ 135 M
  • 60-Month Beta 0.80
  • Price/Sales 1.03
  • Price/Cash Flow 8.02
  • Price/Book 3.43

Options Overview Details

View History
  • Implied Volatility 130.76% (+2.39%)
  • Historical Volatility 35.41%
  • IV Percentile 74%
  • IV Rank 35.93%
  • IV High 308.26% on 11/19/25
  • IV Low 31.23% on 09/04/25
  • Expected Move (DTE 26) 1.57 (18.33%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 90
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 2,427
  • Open Int (30-Day) 2,290
  • Expected Range 7.01 to 10.15

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.22
  • Number of Estimates 1
  • High Estimate 0.22
  • Low Estimate 0.22
  • Prior Year 0.15
  • Growth Rate Est. (year over year) +46.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.59 +13.04%
on 01/29/26
9.03 -4.98%
on 02/09/26
+0.87 (+11.28%)
since 01/20/26
3-Month
6.47 +32.61%
on 11/21/25
9.03 -4.98%
on 02/09/26
+2.05 (+31.39%)
since 11/20/25
52-Week
5.81 +47.68%
on 08/05/25
11.25 -23.73%
on 03/11/25
-1.37 (-13.77%)
since 02/20/25

Most Recent Stories

More News
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference

DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Chief Executive Officer, will present...

BVS : 8.58 (unch)
HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

BVS : 8.58 (unch)
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference

DURHAM, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Bioventus President and Chief Executive...

BVS : 8.58 (unch)
Bioventus: Q3 Earnings Snapshot

Bioventus: Q3 Earnings Snapshot

BVS : 8.58 (unch)
Bioventus Reports Third Quarter Financial Results

Q3 reported revenue of $138.7 million was comparable to last year and organic* revenue advanced 8% Third quarter GAAP earnings of $0.05 per diluted share increased compared to the prior-year...

BVS : 8.58 (unch)
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025

DURHAM, N.C., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will...

BVS : 8.58 (unch)
Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

BVS : 8.58 (unch)
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

DURHAM, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President...

BVS : 8.58 (unch)
Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference

DURHAM, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Bioventus President and Chief Executive...

BVS : 8.58 (unch)
Bioventus: Q2 Earnings Snapshot

Bioventus: Q2 Earnings Snapshot

BVS : 8.58 (unch)

Business Summary

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

See More

Key Turning Points

3rd Resistance Point 8.96
2nd Resistance Point 8.80
1st Resistance Point 8.69
Last Price 8.58
1st Support Level 8.42
2nd Support Level 8.26
3rd Support Level 8.15

See More

52-Week High 11.25
Fibonacci 61.8% 9.17
Last Price 8.58
Fibonacci 50% 8.53
Fibonacci 38.2% 7.89
52-Week Low 5.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar